Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger B Cohen

Showing results (41-50 of 208) with videos related to

Pageof 21
Sort By:
Integrative Cancer Therapies|April 27, 2016
Acupuncture for Dyspnea in Lung Cancer: Results of a Feasibility TrialJoshua Bauml, Andrew Haas, Charles B Simone, et al.
JAMA Otolaryngology-- Head & Neck Surgery|June 22, 2023
Risk of Cardiovascular Events Among Patients With Head and Neck CancerLova Sun, Robert Brody, Danielle Candelieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2014
Phase I dose-escalation study of LCL161, an oral inhibitor of apoptosis proteins inhibitor, in patients with advanced solid tumorsJeffrey R Infante, E Claire Dees, Anthony J Olszanski, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 12, 2015
Statistical Considerations in Clinical Trial Design of Immunotherapeutic Cancer AgentsGeorge Dranitsaris, Roger B Cohen, Gary Acton, et al.
Clinical Lung Cancer|January 24, 2018
Effect of Prophylactic Cranial Irradiation on Overall Survival in Metastatic Small-Cell Lung Cancer: A Propensity Score-Matched AnalysisSonam Sharma, Matthew T McMillan, Abigail Doucette, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 3, 2007
A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (E1500)Kishan J Pandya, Suzanne Dahlberg, Manuel Hidalgo, et al.
Investigational New Drugs|May 1, 2025
Safety, tolerability, and preliminary efficacy of nadunolimab, an anti-IL- 1 receptor accessory protein monoclonal antibody, in combination with pembrolizumab in patients with solid tumorsRoger B Cohen, Antonio Jimeno, Jennifer Hreno, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2007
The 2007 Inaugural ASTRO/ASCO/AHNS Multidisciplinary Head and Neck Cancer SymposiumPaul M Harari, Roger B Cohen, David Raben, et al.
JTO Clinical and Research Reports|May 27, 2024
Brief Report: Long-Term Follow-Up of Adjuvant Pembrolizumab After Locally Ablative Therapy for Oligometastatic NSCLCDavid J Cantor, Christiana Davis, Christine Ciunci, et al.
Annals of Translational Medicine|October 24, 2017
Emerging uses of circulating tumor DNA in advanced stage non-small cell lung cancerMelina Marmarelis, Jeffrey C Thompson, Charu Aggarwal, et al.
Pageof 21

Showing results (41-50 of 208) with videos related to

Sort By:
Pageof 21
Integrative Cancer Therapies|April 27, 2016
Acupuncture for Dyspnea in Lung Cancer: Results of a Feasibility TrialJoshua Bauml, Andrew Haas, Charles B Simone, et al.
JAMA Otolaryngology-- Head & Neck Surgery|June 22, 2023
Risk of Cardiovascular Events Among Patients With Head and Neck CancerLova Sun, Robert Brody, Danielle Candelieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2014
Phase I dose-escalation study of LCL161, an oral inhibitor of apoptosis proteins inhibitor, in patients with advanced solid tumorsJeffrey R Infante, E Claire Dees, Anthony J Olszanski, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 12, 2015
Statistical Considerations in Clinical Trial Design of Immunotherapeutic Cancer AgentsGeorge Dranitsaris, Roger B Cohen, Gary Acton, et al.
Clinical Lung Cancer|January 24, 2018
Effect of Prophylactic Cranial Irradiation on Overall Survival in Metastatic Small-Cell Lung Cancer: A Propensity Score-Matched AnalysisSonam Sharma, Matthew T McMillan, Abigail Doucette, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 3, 2007
A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (E1500)Kishan J Pandya, Suzanne Dahlberg, Manuel Hidalgo, et al.
Investigational New Drugs|May 1, 2025
Safety, tolerability, and preliminary efficacy of nadunolimab, an anti-IL- 1 receptor accessory protein monoclonal antibody, in combination with pembrolizumab in patients with solid tumorsRoger B Cohen, Antonio Jimeno, Jennifer Hreno, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2007
The 2007 Inaugural ASTRO/ASCO/AHNS Multidisciplinary Head and Neck Cancer SymposiumPaul M Harari, Roger B Cohen, David Raben, et al.
JTO Clinical and Research Reports|May 27, 2024
Brief Report: Long-Term Follow-Up of Adjuvant Pembrolizumab After Locally Ablative Therapy for Oligometastatic NSCLCDavid J Cantor, Christiana Davis, Christine Ciunci, et al.
Annals of Translational Medicine|October 24, 2017
Emerging uses of circulating tumor DNA in advanced stage non-small cell lung cancerMelina Marmarelis, Jeffrey C Thompson, Charu Aggarwal, et al.
Pageof 21